Nephrotic syndrome with extensive mesangiolysis as a clinical manifestation of chronic graft-versus-host disease (GVHD)

International Journal of Hematology

Volumn 82, Issue 3, 2005, Pages 270-272

  Kawakami, Keiki ^a   Watanabe, Yasuyuki ^a   Mukai, Katsumi ^a   Takagi, Mikio ^a   Murata, Tetsuya ^a   Gotoh, Tomoko ^a   Kitano, Shigehisa ^b  

^a SUZUKA GENERAL HOSPITAL   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMATINIB; METHOTREXATE; PREDNISOLONE; TACROLIMUS;

ADOLESCENT; ALLOGENEIC STEM CELL TRANSPLANTATION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; LETTER; MALE; MESANGIOLYSIS; MESANGIUM CELL; NEPHROTIC SYNDROME; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROTEINURIA; PURE RED CELL ANEMIA; RASH;

ADOLESCENT; GLOMERULAR MESANGIUM; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; NEPHROTIC SYNDROME;

EID: 27644502352     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05074     Document Type: Letter

References (10)

1. Kansu E. The pathophysiology of chronic graft-versus-host disease. Int J Hematol. 2004;79:209-215.
2. Graze PR, Gale RP. Chronic graft-versus-host disease: a syndrome of disordered immunity. Am J Med. 1979;66:611-620.
3. Shulman H, Striker G, Deeg H, Kennedy M, Storb R, Thomas ED. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation. Glomerular thromboses and tubular injury. New Engl J Med. 1981;305:1392-1395.
4. Ikee R, Yamamoto K, Kushiyama T, Imakiire T, Suzuki S, Miura S. Recurrent nephrotic syndrome associated with graft-versus-host disease. Bone Marrow Transplant. 2004;34:1005-1006.
5. Oliveira JSR, Bahia D, Franco M, Balda C, Stella S, Kerbauty J. Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal. Bone Marrow Transplant. 1999;23:99-101.
6. Bruijin JA, van Eleven EH, Hogendoorn PCW et al. Murine chronic graft-versus-host disease as a model for lupus nephritis. Am J Pathol. 1988;130:639-641.
7. Hirano T, Akashi T, Keira T, et al. Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome. Clin Pharmacol Ther. 2000;68:532-540.
8. Leontsini M. Mesangiolysis. Hippokratia. 2003;7:147-151.
9. Hebert MJ, Fish D, Madore F, et al. Mesangiolysis associated with bone marrow transplantation: new insights on possible etiologic factors. Am J Kidney Dis. 1994;23:882-883.
10. Antignac C, Gubler MC, Leverger G, Broyer M, Habib R. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int. 1989;35:1336-1344.